Human SMAD4 Genomic Variants Identified in Individuals with Heritable and Early-Onset Thoracic Aortic Disease
Cardiogenetics · 2021
DOI: 10.3390/cardiogenetics11030015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiogenetics, 2021. Verfasst von Shreyas A Bhave und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, US. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NHGRI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Thoracic aortic aneurysms (TAAs) that progress to acute thoracic aortic dissections (TADs) are life-threatening vascular events that have been associated with altered transforming growth factor (TGF) β signaling. In addition to TAA, multiple genetic vascular disorders, including hereditary hemorrhagic telangiectasia (HHT), involve altered TGFβ signaling and vascular malformations. Due to the importance of TGFβ, genomic variant databases have been curated for activin receptor-like kinase 1 (ALK1) and endoglin (ENG). This case report details seven variants in SMAD4 that are associated with either heritable or early-onset aortic dissections and compares them to pathogenic exon variants in gnomAD v2.1.1. The TAA and TAD variants were identified through whole exome sequencing of 346 families with unrelated heritable thoracic aortic disease (HTAD) and 355 individuals with early-onset (age ≤ 56 years old) thoracic aortic dissection (ESTAD). An allele frequency filter of less than 0.05% was applied in the Genome Aggregation Database (gnomAD exome v2.1.1) with a combined annotation-dependent depletion score (CADD) greater than 20. These seven variants also have a higher REVEL score (>0.2), indicating pathogenic potential. Further in vivo and in vitro analysis is needed to evaluate how these variants affect SMAD4 mRNA stability and protein activity in association with thoracic aortic disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, US.
- Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, Texas, US.
- Division of Cardiology, University of Washington School of Medicine, Seattle, WA, US.
- Genome Sciences, University of Washington, Seattle, Washington, US.
- Mother Infant Research Institute, Tufts Medical Center, Boston, MA, US.
Förderung
- NICHD NIH HHS
- NHGRI NIH HHS
- NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- American Heart Association
- John Ritter Foundation
- Remembrin’ Benjamin
Zitieren
APA
Bhave, S. A., Guo, D. C., Angelov, S., Bamshad, M. J., Nickerson, D. A., Milewicz, D., & Wallingford, M. C. (2021). Human SMAD4 Genomic Variants Identified in Individuals with Heritable and Early-Onset Thoracic Aortic Disease. Cardiogenetics. https://doi.org/10.3390/cardiogenetics11030015
Vancouver
Bhave SA, Guo DC, Angelov S, Bamshad MJ, Nickerson DA, Milewicz D, et al. Human SMAD4 Genomic Variants Identified in Individuals with Heritable and Early-Onset Thoracic Aortic Disease. Cardiogenetics. 2021. doi:10.3390/cardiogenetics11030015
BibTeX
@article{Bhave2021,
author = {Bhave, Shreyas A and Guo, Dong-Chuan and Angelov, Stoyan and Bamshad, Michael J and Nickerson, Deborah A and Milewicz, Dianna and Wallingford, Mary C},
title = {Human SMAD4 Genomic Variants Identified in Individuals with Heritable and Early-Onset Thoracic Aortic Disease},
journal = {Cardiogenetics},
year = {2021},
doi = {10.3390/cardiogenetics11030015}
}
EUVIMED